These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 18606868)
1. Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. Flores M; Saavedra R; Bautista R; Viedma R; Tenorio EP; Leng L; Sánchez Y; Juárez I; Satoskar AA; Shenoy AS; Terrazas LI; Bucala R; Barbi J; Satoskar AR; Rodriguez-Sosa M FASEB J; 2008 Oct; 22(10):3661-71. PubMed ID: 18606868 [TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection. Terrazas CA; Juarez I; Terrazas LI; Saavedra R; Calleja EA; Rodriguez-Sosa M Exp Parasitol; 2010 Nov; 126(3):348-58. PubMed ID: 20331989 [TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection. Kim JH; Lee J; Bae SJ; Kim Y; Park BJ; Choi JW; Kwon J; Cha GH; Yoo HJ; Jo EK; Bae YS; Lee YH; Yuk JM Sci Rep; 2017 Jul; 7(1):6361. PubMed ID: 28743960 [TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection. Marcon CF; Ferreira PTM; Franco PS; Ribeiro M; Silva RJ; Sousa RAP; Oliveira CJF; Rodrigues Junior V; Gomes MLM; Lazo Chica JE; Mineo TWP; Mineo JR; Barbosa BF; Ferro EAV; Gomes AO Cytokine; 2020 Dec; 136():155283. PubMed ID: 32947151 [TBL] [Abstract][Full Text] [Related]
5. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions]. Deckert-Schlüter M Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413 [TBL] [Abstract][Full Text] [Related]
6. MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis. Ruiz-Rosado Jde D; Olguín JE; Juárez-Avelar I; Saavedra R; Terrazas LI; Robledo-Avila FH; Vazquez-Mendoza A; Fernández J; Satoskar AR; Partida-Sánchez S; Rodriguez-Sosa M Mediators Inflamm; 2016; 2016():9101762. PubMed ID: 27057101 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808 [TBL] [Abstract][Full Text] [Related]
9. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor regulates innate γδ T-cell responses Kim HK; Garcia AB; Siu E; Tilstam P; Das R; Roberts S; Leng L; Bucala R FASEB J; 2019 Jun; 33(6):6919-6932. PubMed ID: 30817226 [TBL] [Abstract][Full Text] [Related]
12. Galectin-3 and Galectin-9 May Differently Regulate the Expressions of Microglial M1/M2 Markers and T Helper 1/Th2 Cytokines in the Brains of Genetically Susceptible C57BL/6 and Resistant BALB/c Mice Following Peroral Infection With Liu J; Huang S; Lu F Front Immunol; 2018; 9():1648. PubMed ID: 30108583 [TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway. Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873 [TBL] [Abstract][Full Text] [Related]
14. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Brown CR; Hunter CA; Estes RG; Beckmann E; Forman J; David C; Remington JS; McLeod R Immunology; 1995 Jul; 85(3):419-28. PubMed ID: 7558130 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types. Angeloni MB; Silva NM; Castro AS; Gomes AO; Silva DA; Mineo JR; Ferro EA Placenta; 2009 Sep; 30(9):785-91. PubMed ID: 19643475 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1/2 phosphorylation and prostaglandin E2 production. Barbosa BF; Paulesu L; Ietta F; Bechi N; Romagnoli R; Gomes AO; Favoreto-Junior S; Silva DA; Mineo JR; Mineo TW; Ferro EA Placenta; 2014 Mar; 35(3):152-62. PubMed ID: 24433846 [TBL] [Abstract][Full Text] [Related]
17. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Wang X; Kang H; Kikuchi T; Suzuki Y Infect Immun; 2004 Aug; 72(8):4432-8. PubMed ID: 15271900 [TBL] [Abstract][Full Text] [Related]
18. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Johnson LL; Sayles PC Infect Immun; 2002 Jan; 70(1):185-91. PubMed ID: 11748181 [TBL] [Abstract][Full Text] [Related]
19. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus. Stojanovic I; Mirkov I; Kataranovski M; Glamoclija J; Stosic-Grujicic S Immunobiology; 2011 Sep; 216(9):1018-27. PubMed ID: 21489649 [TBL] [Abstract][Full Text] [Related]
20. Altered Macrophage and Dendritic Cell Response in Sánchez-Zamora YI; Juarez-Avelar I; Vazquez-Mendoza A; Hiriart M; Rodriguez-Sosa M J Diabetes Res; 2016; 2016():7053963. PubMed ID: 27699180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]